about us news
home
about us
technology
business development
news
career opportunity
contact us

 

smarter biologics    I    university research    I    board of directors   I    FAQs

Board of Directors

William C. Fioretti, chairman of the board, is a co-founder of TransGenRx and has been a director and president of the company since November 2003. He became Chief Executive Officer of the company in July 2004. Mr. Fioretti also has been Chief Executive Officer and Chairman of the Board of Agritech Technologies Ltd. since 1991 and Chairman of the Board of NanoMatrix, Inc. since 2001. Each of such companies is a privately owned biotech company. Fioretti was a founder of Mannatech™ Incorporated, a publicly traded nutritional supplement company, and served as its Chief Executive Officer and Chief Science Officer from 1994 to 1998. Mr. Fioretti received a Bachelor of Science from Appalachian State University in 1974; he did graduate work in biochemistry at the Medical University of South Carolina from 1974 to 1978 and engaged in postgraduate studies at the University of Florida from 1978 to 1980.

Dr. Richard K. Cooper has been Executive Vice President - Research and Development of TransGenRx since November 2003. Since 1991, Dr. Cooper has been a professor at Louisiana State University, where he holds a joint appointment at the LSU Agricultural Center and the LSU School of Veterinary Medicine. Dr. Cooper received a Bachelor of Science degree from Mississippi College in 1985, a Master of Science degree from Mississippi State University in 1988 and a Ph.D. from the University of Georgia in 1991.

John David Barley has been a director of the company since July 2004. Mr. Barley is the founder and owner of Palm Beach Land Trust, a real estate investment brokerage firm in Florida. Mr. Barley also has been the Chairman of Golf Worldwide, a company that provides brokerage and consulting services to the golfing industry, since 1995. Mr. Barley received a degree in finance in 1966 and a Juris Doctorate from the University of Miami in 1969.

John Gallagher has been Corporate Counsel to TransGenRx since November 2005 and a director of the company since September 2004. Since 2002, Mr. Gallagher, an attorney, has served as general counsel to Genendo Pharmaceutical, a company engaged in the business of buying and selling pharmaceuticals in the international market. From 1997 to 2001, Mr. Gallagher served as Co-Chairman and Co-President of European Micro Holdings, Inc., a publicly traded distributor of microcomputer products. Mr. Gallagher received a Bachelor of Arts degree in 1976, and a Juris Doctorate from the University of Florida in 1978.

Dennis Hayes has been a director of the company since October 2005. Mr. Hayes, an attorney, has been in private practice since 1971, concentrating on business organizations, funding, operations and transactions, real estate and criminal defense. Mr. Hayes received a Bachelor of Arts degree in political science and economics from St. Ambrose College in 1964, and a Juris Doctorate from Wayne State University School of Law in 1967.
141 Wilson Laboratories · Baton Rouge, LA 70803 · 1-888-432-0721 · info@tgrx.com
 © Copyright 2006 TransGenRx All rights reserved.